EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
-7.88%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.07B
AUM Growth
-$29.7M
(-2.7%)
Cap. Flow
+$88.7M
Cap. Flow
% of AUM
8.26%
Top 10 Holdings %
Top 10 Hldgs %
55.73%
Holding
349
New
26
Increased
163
Reduced
134
Closed
15
Top Buys
| 1 |
TSMC
TSM
|
$29.5M |
| 2 |
Grab
GRAB
|
$28.9M |
| 3 |
Qualcomm
QCOM
|
$21.2M |
| 4 |
Advanced Micro Devices
AMD
|
$16.3M |
| 5 |
Sea Limited
SE
|
$14.7M |
Top Sells
| 1 |
Mercado Libre
MELI
|
$25.6M |
| 2 |
Meta Platforms (Facebook)
META
|
$13.4M |
| 3 |
DIDI
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
|
$6.5M |
| 4 |
IMAB
I-MAB
IMAB
|
$1.24M |
| 5 |
ProShares Ultra Gold
UGL
|
$1.01M |
Sector Composition
| 1 | Consumer Discretionary | 34.29% |
| 2 | Technology | 26.19% |
| 3 | Communication Services | 11.91% |
| 4 | Healthcare | 11.24% |
| 5 | Real Estate | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
Lucid Motors
LCID
$5.66B
| $236K | 0.02% |
1,689
+96
| +6% | +$13.4K |
|
277
HP
HPQ
$27.4B
| $230K | 0.02% |
9,248
-1,848
| -17% | -$46K |
|
|
CDMO
278
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $229K | 0.02% |
11,979
-2,015
| -14% | -$38.5K |
|
279
Arcutis Biotherapeutics
ARQT
$2.06B
| $228K | 0.02% |
+11,947
| New | +$228K |
|
280
Boston Scientific
BSX
$159B
| $228K | 0.02% |
5,875
+382
| +7% | +$14.8K |
|
281
Enanta Pharmaceuticals
ENTA
$189M
| $227K | 0.02% |
4,381
-1,939
| -31% | -$100K |
|
282
Gartner
IT
$18.6B
| $225K | 0.02% |
812
-38
| -4% | -$10.5K |
|
283
Myriad Genetics
MYGN
$615M
| $225K | 0.02% |
11,783
-698
| -6% | -$13.3K |
|
284
Vericel Corp
VCEL
$1.72B
| $225K | 0.02% |
9,701
-1,796
| -16% | -$41.7K |
|
285
Corning
GLW
$61B
| $222K | 0.02% |
7,638
-359
| -4% | -$10.4K |
|
286
Charles Schwab
SCHW
$167B
| $222K | 0.02% |
+3,092
| New | +$222K |
|
287
Zscaler
ZS
$42.7B
| $221K | 0.02% |
1,347
| – | – |
|
288
Inovio Pharmaceuticals
INO
$148M
| $220K | 0.02% |
10,640
-3,316
| -24% | -$68.6K |
|
289
McKesson
MCK
$85.5B
| $219K | 0.02% |
+645
| New | +$219K |
|
290
Morgan Stanley
MS
$236B
| $219K | 0.02% |
2,769
-10
| -0.4% | -$791 |
|
291
AT&T
T
$212B
| $217K | 0.02% |
14,163
-52
| -0.4% | -$797 |
|
292
Ligand Pharmaceuticals
LGND
$3.25B
| $216K | 0.02% |
4,012
-1,151
| -22% | -$62K |
|
|
ICPT
293
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $216K | 0.02% |
15,508
-2,051
| -12% | -$28.6K |
|
294
Cogent Biosciences
COGT
$1.82B
| $215K | 0.02% |
+14,390
| New | +$215K |
|
295
SiriusXM
SIRI
$8.1B
| $215K | 0.02% |
3,761
| – | – |
|
296
Edwards Lifesciences
EW
$47.5B
| $213K | 0.02% |
2,575
+278
| +12% | +$23K |
|
297
Regenxbio
RGNX
$490M
| $213K | 0.02% |
8,055
-912
| -10% | -$24.1K |
|
298
CDW
CDW
$22.2B
| $212K | 0.02% |
1,357
-63
| -4% | -$9.84K |
|
299
S&P Global
SPGI
$164B
| $210K | 0.02% |
687
-4
| -0.6% | -$1.22K |
|
300
EPAM Systems
EPAM
$9.44B
| $208K | 0.02% |
+573
| New | +$208K |
|